M. Welshinger et al., EXPRESSION OF A-BLOOD-GROUP, B-BLOOD-GROUP, AND H-BLOOD-GROUP ANTIGENS IN EPITHELIAL OVARIAN-CANCER - RELATIONSHIP TO TUMOR GRADE AND PATIENT SURVIVAL, Gynecologic oncology, 62(1), 1996, pp. 106-112
The expression of A, B, and H blood group antigens in epithelial ovari
an cancer was evaluated in 137 patients with advanced disease by stain
ing frozen sections with specific monoclonal antibodies using an indir
ect immunoperoxidase method, Expression of blood group antigens was ob
served in a proportion of ovarian carcinomas and in some areas of ovar
ian surface epithelium. Forty-eight percent of the tumors tested from
130 blood group A, B, or O individuals showed no expression of the app
ropriate blood group antigen, 32% had heterogeneous antigen expression
, and 20% had strong expression. In the 7 blood group AB patients stud
ied, no expression, heterogeneous expression of both antigens, or abse
nce of one, but not the other antigen, was observed. No tumor showed A
, B, or H antigen expression that was not compatible with the patient'
s blood group type. Histologic Grade 3 tumors showed absence of blood
group antigen expression more often than did Grade 2 tumors. The prese
nce or absence of A, B, or H antigen expression did not correlate with
survival in this group of patients. This is in contrast to studies in
other epithelial tumor types in which the normal epithelium synthesiz
es blood group antigens and loss of ABH antigen expression is observed
in the corresponding tumors. (C) 1996 Academic Press, Inc.